|
Phase 1b study of aldoxorubicin + gemcitabine in metastatic solid tumors. |
|
|
Research Funding - CytRx Corporation (Inst) |
|
|
Employment - CytRx Corporation |
|
|
No Relationships to Disclose |
|
|
Research Funding - CytRx Corporation (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - CytRx Corporation |
|
|
Research Funding - CytRx Corporation (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - CytRx Corporation |
Leadership - CytRx Corporation |
Stock and Other Ownership Interests - CytRx Corporation |
|
|
No Relationships to Disclose |
|
|
Research Funding - CytRx Corporation (Inst) |